At a glance
ClinicalIndex Comparison RecordN/AUnknown· 30 target
Drug / intervention
Erector spinae plane blockprocedure
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Postoperative Analgesia With Erector Spinae Plane Block After Pectus Excavatum Repair in Children
In Brief
A clinical study evaluating Erector spinae plane block for Pectus Excavatum. Targeting 30 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate the efficacy of erector spinae plane (ESP) block in children after pectus excavatum repair (nuss procedure).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPectus Excavatum
CountriesSouth Korea
Collaborators--
Timeline
N/AUnknownOverdue
2020202120222023202420252026
First PostedSep 2019
Enrollment StartFeb 2020
Primary CompletionSep 2023
Study CompletionDec 2023
TodayJul 2026
First PostedSep 9, 2019
Enrollment StartFeb 10, 2020
Primary CompletionSep 30, 2023
Study CompletionDec 30, 2023
TodayJul 1, 2026
Enrollment to primary: 3.6 yearsPosted 6.8 years ago
Interventions
Erector spinae plane blockprocedure
Using ultrasound, place the needle in the erector spinae fascia plane at T7-8 level. Then, 0.25% ropivacaine 0.5 ml is injected to confirm the needle location. After checking the location, 0.25% ropivacaine 0.5 ml/kg is administered. This procedure is repeated at contralateral side.